Tag: the future of laboratory medicine

Pathologists Can Offer ‘Companion Informatics’

CEO SUMMARY: Community hospitals are recognizing increased interest in personalized medicine among consumers. One expert predicts that this will create opportunities for hospital labs and pathology groups to add value by offering subspecialty expertise in molecular diagnostics, genetic testing, and “companion informatics.” At the University of Louisville School of Medicine, the Department of Pathology and

View Article

Lean, Six Sigma and Laboratory Errors

IT IS TOUGH TO IGNORE THE STEADY DRUMBEAT about patient safety. In every sector of healthcare, accrediting bodies, state legislatures, private insurers, and federal health administrators are instituting programs designed to focus providers on eliminating the sources of medical errors and reducing the variability in care provided to patients.

As you will read on pages 17-18,

View Article

LabCorp’s MacMahon Provides Insights About Lab Marketplace

CEO SUMMARY: Pathologists will be particularly interested in what Thomas MacMahon has to say about the evolution of laboratory medicine. As Chairman, President, and CEO of Laboratory Corporation of America Holdings, he has continuous access to some of the best strategic analysis about the laboratory testing marketplace and its evolution. MacMahon has several surprising predictions

View Article

Ortho-Clinical Diagnostics Embraces New Testing Technology

CEO SUMMARY: Despite a decade of consolidation, competition among the world’s largest diagnostics manufacturers remains intense. In response to this competition, Ortho-Clinical Diagnostics (OCD) is preparing a variety of new products and services for its clinical laboratory customers. It’s already exploring diagnostic opportunities in the emerging field of pharmacogenomics. In the field of laboratory management,

View Article

Plenty Of Money To Go Around

Despite what managed care is doing to clinical laboratories, money abounds to sell more goods. In this issue, you will read about how AmeriPath, Inc. is about to raise $71.7 million while Cytyc Corp. intends to generate $48.2 million in its second public offering in 12 months.

The list of laboratory-related companies which raised money during

View Article